GlaxoSmithKline Biologicals
Rixensart, Antwerpen, Belgium
Purpose
to provide a new dimension to vaccine development for malaria and tuberculosis (TB) by deeper analysis of transcriptomics data that are being generated in clinical studies, by promoting collaboration between different partners involved in S
Division
Global Health
Date
January 2015
Region Served
GLOBAL
Committed amount
$980,144
Grant topic
Discovery and Translational Sciences
Duration (months)
47
Grantee location
Rixensart, Antwerpen, Belgium
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.